These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25066268)

  • 1. Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease?
    Probert CS; Reade S; Ahmed I
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1129-31. PubMed ID: 25066268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.
    Raman M; Ahmed I; Gillevet PM; Probert CS; Ratcliffe NM; Smith S; Greenwood R; Sikaroodi M; Lam V; Crotty P; Bailey J; Myers RP; Rioux KP
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):868-75.e1-3. PubMed ID: 23454028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
    Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
    World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of fecal volatile organic compounds as biomarkers of chemically induced intestinal inflammation in mice.
    Reade S; Williams JM; Aggio R; Duckworth CA; Mahalhal A; Hough R; Pritchard DM; Probert CS
    FASEB J; 2019 Mar; 33(3):3129-3136. PubMed ID: 30359099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of faecal gas analysis for the diagnosis of IBD.
    Probert CS
    Biochem Soc Trans; 2011 Aug; 39(4):1079-80. PubMed ID: 21787351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review.
    Ahmed I; Fayyaz F; Nasir M; Niaz Z; Furnari M; Perry L
    Scand J Gastroenterol; 2016; 51(4):385-92. PubMed ID: 26541790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
    Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
    Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.
    El Manouni El Hassani S; Bosch S; Lemmen JPM; Brizzio Brentar M; Ayada I; Wicaksono AN; Covington JA; Benninga MA; de Boer NKH; de Meij TGJ
    Sensors (Basel); 2019 Oct; 19(20):. PubMed ID: 31623289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
    Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
    Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compounds.
    Boursier J; Rawls JF; Diehl AM
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):876-8. PubMed ID: 23628504
    [No Abstract]   [Full Text] [Related]  

  • 14. Faecal Volatile Organic Compound Analysis in De Novo Paediatric Inflammatory Bowel Disease by Gas Chromatography-Ion Mobility Spectrometry: A Case-Control Study.
    Vermeer E; Jagt JZ; Stewart TK; Covington JA; Struys EA; de Jonge R; de Boer NKH; de Meij TGJ
    Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: breath analysis in inflammatory bowel diseases.
    Kurada S; Alkhouri N; Fiocchi C; Dweik R; Rieder F
    Aliment Pharmacol Ther; 2015 Feb; 41(4):329-41. PubMed ID: 25523187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the intestinal microbiota and fecal transplantation in inflammatory bowel diseases.
    Liang J; Sha SM; Wu KC
    J Dig Dis; 2014 Dec; 15(12):641-6. PubMed ID: 25389085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiota and inflammatory bowel disease.
    Matsuoka K; Kanai T
    Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sniffing out causes of gastrointestinal disorders: a review of volatile metabolomic biomarkers.
    Ahmed I; Niaz Z; Ewbank F; Akarca D; Felwick R; Furnari M
    Biomark Med; 2018 Oct; 12(10):1139-1148. PubMed ID: 30191735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review.
    Zhang VR; Ramachandran GK; Loo EXL; Soh AYS; Yong WP; Siah KTH
    Neurogastroenterol Motil; 2023 Jul; 35(7):e14536. PubMed ID: 36780514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
    Shanahan F; Quigley EM
    Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.